
Normal-phase chromatography remains a powerful separation strategy for structurally similar, polarity-sensitive, lipophilic, and isomeric compounds that are difficult to resolve by reversed-phase methods alone. For pharmaceutical researchers, medicinal chemists, natural product scientists, and drug development teams, poor chromatographic selectivity can delay impurity profiling, compound isolation, reference material preparation, and scale-up purification. BOC Sciences provides customized normal-phase chromatography services covering method scouting, silica-based separation, flash chromatography, preparative HPLC purification, fraction analysis, and process-oriented scale-up. Our scientists design separation workflows around compound polarity, functional groups, adsorption behavior, solvent compatibility, loading capacity, and downstream analytical needs, helping clients obtain cleaner fractions, clearer impurity information, and dependable purified materials for subsequent research.
BOC Sciences develops fit-for-purpose separation strategies through structured solvent, stationary phase, and elution condition screening. Our analysis and purification platform supports rapid decision-making for compounds with challenging polarity and retention behavior.
For rapid purification of synthetic intermediates, natural product fractions, and reaction mixtures, we apply flash column chromatography with optimized loading, gradient design, and fraction tracking.
When flash chromatography cannot provide sufficient resolution, BOC Sciences uses preparative HPLC to isolate target compounds, positional isomers, diastereomers, and low-level impurity fractions with enhanced precision.
For molecules with unusual polarity, instability, adsorption loss, or complex impurity profiles, we provide custom purification services that combine normal-phase chromatography with complementary analytical and purification approaches.
BOC Sciences helps drug discovery and development teams improve selectivity, isolate valuable compounds, and obtain decision-ready purification data.

We apply high-quality silica phases to exploit hydrogen bonding, dipole interactions, adsorption differences, and polarity-driven retention, enabling efficient separation of aromatic compounds, lipids, alkaloids, steroids, and synthetic intermediates.

Amino, cyano, and diol phases provide alternative selectivity when bare silica causes excessive retention, peak tailing, or irreversible adsorption, improving method flexibility for polar and moderately polar analytes.

Our preparative chromatography workflows are configured for milligram-to-gram purification, combining suitable column dimensions, flow rates, injection strategies, and collection windows for dependable compound recovery.

UV, ELSD, CAD, MS, and fraction-based analytical confirmation help track chromophoric and non-chromophoric analytes, supporting more confident fraction selection for structurally diverse compounds.

Through our analytical platform, purified fractions can be assessed by HPLC, UHPLC, LC-MS, NMR, and related techniques to support identity, composition, and impurity understanding.

We translate small-scale scouting results into practical purification runs by optimizing loading level, solvent strength, gradient slope, column size, collection strategy, and post-run fraction concentration.
BOC Sciences provides normal-phase chromatography services for a wide range of pharmaceutical research materials. Our team evaluates each sample based on polarity, solubility, stability, impurity pattern, and available material quantity, then recommends a practical separation route that protects valuable compounds while improving chromatographic resolution.
Send us your structure, crude profile, target fraction, or current chromatogram. BOC Sciences will recommend a normal-phase separation strategy tailored to your compound class and project objective.

We review the compound structure, crude chromatogram, solubility profile, available quantity, target purity range, impurity concerns, and intended downstream use to define the most appropriate normal-phase strategy.

Our scientists screen stationary phases, solvent ratios, modifiers, loading formats, gradient slopes, and detection modes, then select a method that provides strong selectivity with practical recovery.

The optimized method is applied to flash chromatography or preparative HPLC runs. Fractions are collected according to chromatographic signals and analyzed to support accurate pooling decisions.

Purified materials are concentrated, prepared according to project needs, and accompanied by chromatograms, analytical results, method notes, fraction information, and practical recommendations for future runs.
Medicinal chemistry programs often generate analog series with nearly identical reversed-phase retention. BOC Sciences uses normal-phase selectivity to separate compounds through adsorption strength, functional group interaction, and polarity differences, enabling clearer isolation of target analogs from regioisomers, incomplete reaction products, and structurally related byproducts.
Basic, acidic, or multifunctional compounds may tail severely on silica or bind too strongly under standard conditions. We adjust solvent strength, modifier type, stationary phase chemistry, sample loading format, and column conditioning to improve peak symmetry while preserving the separation power of normal-phase chromatography.
When a low-level impurity must be enriched for identification, our team combines targeted fraction collection with impurity isolation and identification workflows. This approach helps clients move from an unresolved impurity peak to a purified fraction suitable for structural characterization.
Some samples require normal-phase conditions to resolve stereochemical complexity. BOC Sciences can combine normal-phase purification with chiral analysis and separation or chiral HPLC when stereoisomeric composition is central to project success.
From early method scouting to preparative purification, BOC Sciences helps clients design normal-phase chromatography workflows that improve separation quality, material recovery, and data confidence.
We do not apply a generic column-and-solvent combination to every project. Our scientists design each separation around chemical structure, polarity, solubility, adsorption behavior, and project purpose.
BOC Sciences connects method scouting, chromatographic purification, and post-run analysis through integrated chromatography testing, helping clients make faster and more confident purification decisions.
Our team selects detection approaches according to compound behavior, including UV for chromophoric molecules, ELSD or CAD for weakly absorbing compounds, and LC-MS testing for mass-directed confirmation.
We optimize purification conditions with future material needs in mind, including solvent practicality, loading tolerance, fraction concentration, repeatability, and compatibility with downstream analytical or synthetic work.
Client Needs: A medicinal chemistry team needed to purify two positional isomers from a substituted benzoxazole analog series. Reversed-phase HPLC showed overlapping peaks, and repeated crystallization produced inconsistent enrichment.
Challenges: The compounds had similar molecular weight, UV response, and reversed-phase retention, while one isomer adsorbed strongly to untreated silica and produced broad peaks under common hexane/ethyl acetate conditions.
Solution: BOC Sciences screened six normal-phase solvent systems across silica, cyano, and diol phases, then selected a modified heptane/ethyl acetate/isopropanol gradient. We optimized dry loading on silica, ran three analytical confirmation cycles, and transferred the method to preparative HPLC with UV-triggered collection and fraction-by-fraction UHPLC review.
Outcome: The target isomer was isolated as a clean fraction with improved recovery, and the client received a reusable chromatographic method for additional analog batches.
Client Needs: A process chemistry group observed an unknown late-eluting impurity in a lipophilic API intermediate and required enriched material for structural investigation.
Challenges: The impurity represented a minor fraction of the crude mixture, co-eluted with a nonpolar side product under reversed-phase conditions, and had weak UV absorbance at standard detection wavelengths.
Solution: We combined normal-phase flash chromatography with ELSD-guided fraction tracking and LC-MS confirmation. After testing eight solvent ratios, the team selected a shallow heptane/MTBE gradient, processed 4.8 g of crude material in two purification runs, and pooled 14 impurity-enriched fractions for concentration and NMR-ready cleanup.
Outcome: The impurity was successfully enriched for structural analysis, allowing the client to adjust reaction conditions and reduce formation of the unwanted byproduct.
Client Needs: A natural product research team needed gram-level purification of a terpenoid-rich plant extract containing multiple nonpolar components with similar reversed-phase behavior.
Challenges: The sample contained pigments, wax-like matrix components, and structurally related terpenoids that caused overloaded peaks, baseline drift, and poor fraction visibility during initial purification attempts.
Solution: BOC Sciences implemented a two-stage purification route: initial silica flash cleanup to remove pigments and waxes, followed by preparative normal-phase HPLC using a hexane/isopropanol gradient. We monitored 36 collected fractions by TLC, UHPLC, and LC-MS, then reprocessed two mixed fractions through a narrower cyano-phase method.
Outcome: The workflow yielded isolated terpenoid fractions suitable for further characterization and reduced sample complexity enough for confident downstream analytical evaluation.
Normal-phase chromatography is particularly effective for separating compounds with significant polarity differences, structurally similar analogs, or species poorly retained in reversed-phase systems. Typical targets include lipids, natural products, chiral intermediates, isomers, sugars, polar impurities, and some hydrophobic drug molecules. For drug development projects, normal-phase chromatography offers complementary selectivity when target compounds cannot be efficiently separated from by-products or degradation products using reversed-phase methods. BOC Sciences can tailor stationary phases, mobile phases, and gradient conditions according to compound polarity, solubility, functional groups, and project goals to maximize separation efficiency and method applicability.
Normal-phase chromatography typically uses a polar stationary phase with relatively nonpolar mobile phases, relying on polarity, hydrogen bonding, dipole interactions, or adsorption strength for separation. Reversed-phase chromatography uses nonpolar stationary phases with aqueous/organic mobile phases, primarily relying on hydrophobic interactions. Compounds that exhibit poor peak shape, weak retention, or insufficient selectivity in reversed-phase chromatography often achieve better separation in normal-phase mode. Drug developers often use both methods complementarily for impurity profiling, isomer separation, purification process development, and complex sample characterization.
Choosing normal-phase conditions requires evaluating the target molecule's polarity, solubility, acid/base properties, functional groups, sample complexity, and desired separation outcome. Key optimization parameters include stationary phase type, mobile phase polarity, additives, gradient or isocratic elution, column temperature, flow rate, and detection method. BOC Sciences typically starts with small-scale screening, comparing selectivity on silica, amino, cyano, diol, or other stationary phases, and then optimizes based on sample response and peak shape, establishing a robust, reproducible, and scalable separation strategy.
Yes. Normal-phase chromatography is applicable for both analytical and preparative purification, ranging from milligram to gram scale, especially for separating structurally similar compounds, non-racemic intermediates, lipid-soluble natural products, and difficult-to-resolve impurities. Key considerations include balancing load capacity, resolution, solvent compatibility, and target component recovery. BOC Sciences designs end-to-end workflows from method screening and scale-up validation to component collection and confirmation, minimizing trial-and-error and maximizing sample utilization according to client needs.
To develop an optimal normal-phase chromatography method, clients should provide the compound structure, sample source, crude composition, estimated content, known impurities, solubility data, stability considerations, and any existing chromatographic or detection results. For projects involving multiple analogs or unknown impurities, providing LC-MS, NMR, or reversed-phase HPLC data is recommended. BOC Sciences uses this information to evaluate separation challenges, determine if preliminary solvent compatibility, stationary phase screening, or detection method matching is required, and create an analysis or purification strategy aligned with project objectives.
BOC Sciences solved a separation problem that had slowed our analog program for weeks. Their normal-phase method clearly separated two isomers that looked almost identical in our reversed-phase screens.
— Dr. Maxwell, Senior Medicinal Chemist
The team did not just run a column; they built a logical purification route. The solvent scouting, fraction analysis, and final pooling recommendation were exactly what our project needed.
— Rhodes, Process Chemistry Manager
We needed enough impurity material for structural work, and BOC Sciences delivered a clean, well-documented enriched fraction. Their ELSD and LC-MS tracking made the data easy to interpret.
— Dr. Fuller, Analytical Development Scientist
Their scientists understood both chromatography and material recovery. The normal-phase method they developed scaled smoothly from screening to preparative purification and preserved our limited sample.
— Griffin, Research Program Lead
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.